FARNUM RHONDA (SVP, Comm & Medical Affairs) sold 6.6% of their position (24K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $264.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2025ACC: 0001415889-25-015642
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-24K
Net shares
Net seller
$264.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
24K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−24K
Price / share
$11.00
Trade value
$264K
% of position
6.6%
6/2/2025
360.92K→336.92K
Total
Net shares
−24K
Net value
-$264K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/2/2025 | S · Sale | −24K | $11.00 | $264K | 6.6% | 360.92K | 336.92K |
| Total | −24K | -$264K | ||||||
Derivative Transactions0
No derivative transactions reported